TMO Stock Chart & Fundamental Analysis

Interactive Chart

About Thermo Fisher Scientific

Name

Thermo Fisher Scientific

CEO

Marc N. Casper

Website

www.thermofisher.com

Industry

Healthcare

Year Founded

2006

Employees

125,000

Thermo Fisher Scientific Inc. is a life-science tools and services company that helps laboratories, manufacturers, and health systems turn experiments into routine outcomes. It supplies technology and know-how for sample preparation, measurement, and regulated production, with delivery models that range from instruments on site to outsourced scientific services. The approach is practical: keep methods consistent, documentation clear, and supply reliable so work can move from discovery to everyday use without constant reinvention. Teams support customers in research, diagnostics, and bioproduction, aligning procedures with standards that travel across regions. By pairing science with service, the company positions itself as infrastructure for modern laboratories and plants rather than a single product bet, aiming to make complex workflows feel predictable in real settings.

Analyst Ratings

Consensus Recommendation

Buy12

Hold7

Sell2

Fundamentals & Financials

Revenue (TTM)

$43.7B

Net Income (TTM)

$6.5B

EPS (TTM)

$17.34

ROA (TTM)

6.38%

Current Ratio

1.5

Dividend Yield

0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)

Item	Q3 2025	Q2 2025	Q1 2025
Revenue	$11,122M	$10,855M	$10,364M
Cost of Sales	$6,470M	$6,807M	$6,119M
Gross Profit	$4,652M	$4,048M	$4,245M
Operating Income	$1,943M	$1,917M	$1,840M
Net Income	$1,616M	$1,617M	$1,507M
EPS	$4.28	$4.28	$3.99

Balance Sheet (Quarterly)

Financial Highlights (Quarterly)

Dividends History

Split History

Earnings Calendar (Quarterly)

Technical Indicators

Thermo Fisher Scientific's Technical Indicators Summary

TMO is currently trading just above its key moving averages, including the 10-day and 200-day EMAs, which generally indicates a bullish trend. Momentum indicators such as the MACD and short-term moving averages support this positive outlook, while the RSI and CCI remain in moderate territory, suggesting neither overbought nor oversold conditions. However, the ADX near 24 points to only a modest trend strength, and the declining On-Balance Volume signals some selling pressure despite stable price levels. Volatility, as measured by the ATR, remains steady, and with the session closed, there is no VWAP data to influence intraday interpretation. Overall, the technical landscape for TMO reflects a balanced stance between upward momentum and caution from volume dynamics.

Buy

12 signals

Neutral

7 signals

Sell

2 signals

Overall: Neutral33% Neutral signals

Indicator	Value	Signal	Explanation
RSI (14)	61.89	Neutral	RSI (61.89) is neutral.
Stochastic %K (14, 3, 3)	85.66	Sell	Stochastic (85.66) > 80, indicating overbought.
CCI (20)	90.10	Neutral	CCI (90.10) is neutral.
WPR (14)	-21.09	Neutral	Williams %R (-21.09) is neutral.
Momentum (10)	26.21	Buy	Momentum (26.21) is positive.
MFI	67.25	Neutral	MFI (67.25) is neutral.
MACD Level (12, 26)	12.21	Buy	Confirmed uptrend: MACD (12.21) is positive and above its signal line (10.31).
Bollinger Bands	$556.22 - $638.61	Neutral	Price is within the bands.
ATR (14)	$13.64 (2.21%)	Neutral	Moderate Volatility (2.21%).
ADX (14)	24.02	Neutral	Weak or consolidating trend (ADX < 25). ADX(24.02), +DI(23.07), -DI(13.95)
OBV	-20,673,400	Sell	Bearish volume pressure: OBV is below its 20-day SMA. OBV(-20,673,400), 20D-SMA-OBV(-19,568,770)
Exponential Moving Averages	$522.23 - $612.59(5 indicators)	Buy	Price is consistently above all key EMA levels (10, 20, 50, 100, and 200), indicating a strong bullish trend across short to long-term periods.
Simple Moving Averages	$490.88 - $616.22(5 indicators)	Buy	The price is above all key SMA levels (10, 20, 50, 100, and 200), indicating a strong bullish trend across short to long-term periods.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

A mid-sized 2.338% climb from yesterday’s close places TMO at 633.48. A cautious bias is visible in options positioning, where PCR has risen to 1.04. TMO shares rise amid news of strategic investments and advancements in forensic technology.

Price Change

from $619.01 close

+$14.47

Trading Volume

Below avg (2.7M)

vs S&P 500 Today

Strong Outperformance

+12.89%

52-Week Position

Near highs

98.2%

Updated: January 21, 2026 at 20:07 UTC